CIO Leadership Series: Phil Loftus, Aurora Health Care
He's in charge of defining and implementing the information services component of Aurora's strategic goal - to provide an integrated approach to the delivery of care. <div class="MugShot...Aurora to install TeraMedica's Evercore technology
, a privately held medical software company.<...Aurora team implants Wisconsin's first total artificial heart
"We are very proud to have been among the first to introduce this new technology to our patients," said Tector, the medical d...Aurora ranks among most wired systems
- Consumers seeking increased connectivity with their healthcare providers hope that digital and Internet-based tools will help reduce medical errors and make services easier to access. Although the streamlining of clinical practices with secure, transferable medical data is evolving piecemeal, a group of Wisconsin hospitals appears to be among the leaders of this technolog...Aurora Health to provide eICU care
MILWAUKEE - , based in Milwaukee, will become the first health system in Wisconsin to offer life-saving eICU technology to its critical-care patients. The eICU solution uses high-fidelity telemedicine, early warning software and electronic monitoring to connect and provide off-site critical care physicians and nurses...Aurobindo gets U.S. FDA approval for Cephalexin
Aurobindo Pharma Ltd has announced that U.S. Food Drug Administration (US FDA) has approved its Cephalexin capsules USP 250 mg & 500 mg.// Cephalexin is used to treat many different types of bacterial infections such as bronchitis, tonsillitis, ear infections, skin infections, and urinary tract infections.The company has achieved another major milestone by obtaining the first product...US FDA approved Aurobindo Pharma to produce generic AIDS drug
The US Food and Drug Association (FDA) has approved Aurobindo Pharma Limited to produce the generic version of oral Stavudine solution// 1 mg/mL, which is used in children for control of HIV treatment. Zerit (Stavudine Oral solution) is produced commercially by Bristol-Myers Squibb which has the patent for the drug which is found to be very effective against HIV. Stavudine is a synthetic...Aurobindo Receives Approval from USFDA for anti-AIDS drug
AIDS patients, the world over, can heave a sigh of relief following the nod of approval from the US Food & Drug Administration// (FDA) for the world’s first anti-AIDS cocktail drug for use as a single dose. The drug manufacturer, Hyderabad-based bulk drugs major Aurobindo Pharma, has made combined anti-retro virals (ARVs) — Retrovir (zidovudine), Epivir (lamivudine) and Viramune (nevira...Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
Aurobindo Pharma today said it has recieved a tentative New Drug Approval from USFDA for its fixed dose combination product used for treating HIV-1 infection//. The new drug approval is for fixed dose combination drug product containing Lamivudine, Zidovudine, Nevirapine tablets used in the treatment of HIV-1 infection, the company informed the Bombay Stock Exchange. The t...Aurobindo Pharma Purchases US Manufacturing Facility
The Hyderabad-based Aurobindo Pharma Ltd today said it has acquired a USFDA compliant manufacturing facility in Dayton, New Jersey//. The facility, spread over 20 acres of freehold land, will serve as the company's US head quarters, it informed the stock exchanges. "This purchase reinforces Aurobindo's commitment to serve US market in an effective manner," Ramprasad Reddy, C...Aurora & Aurora Deluxe PSG - Recording & Review
Description:Aurora is a powerful Windows-based digital PSG instrument providing complete data acquisition, recording and review capabilities in one flexible package. The Aurora offers the most feature-packed PSG system in any price range....EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
ROCKVILLE, Md., June 01, 2007 /PRNewswire-FirstCall/ --EntreMed, Inc. , a clinical-stage pharmaceutical company developingtherapeutics for the treatment of cancer and inflammatory diseases,announced the presentation of preclinical results for its Aurorakinase - angiogenesis inhibitor, ENMD-981693. The data werepresented during oral and poster presentations by EntreMedscientists at the 2n...